Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH names new chair
Caitrina Oakes has been named chair of NOAH for 2021/22.

Vetoquinol MD Caitrina Oakes will lead the association for 2021/22

The National Office of Animal Health (NOAH) has elected Caitrina Oakes, managing director of Vetoquinol UK and Ireland, as its new chair.

Commenting on her appointment, Caitrina set out the areas she would be focussing on over the next 12 months, including the consultation and review of the UK Veterinary Medicines Regulation. 

“We need a regulatory climate to ensure animal medicines availability, as well as to encourage innovation,” she said.

“We are in the final stages of developing detailed proposals that will set out how we believe this might be achieved and look forward to providing any help we can to ensure our new Regulation enables our members, and the benefits their products and innovation brings, to thrive – and continue to protect the health and welfare of our nation’s animals”. 

Caitrina joined the NOAH Board in 2013, the same year she became managing director of Vetoquinol UK and Ireland. Before this, she spent more than 12 years at Hill’s Pet Nutrition in various sales positions, including national sales manager vet channel UK and Ireland. She is also a member of the Membership Working Group and the Trade Sub-Committee. 

Speaking after her appointment, Caitrina said another area of focus for NOAH in the next 12 months would be sustainability: 

“Healthy animals receiving proper nutrition are better able to digest feed and produce lower levels of emissions, while protecting animals against infection – such as through vaccination – reduces the risk of disease, and the need for antibiotics,” she said.

“The Board will be taking forward sustainability improvements, including a sustainability policy for our association. We are looking to see how NOAH can help lead us collectively and collaboratively to aim even higher”. 

Caitrina also highlighted the importance of representation within NOAH, particularly as it moves forward from the pandemic.

“As well as representing around 97 per cent of the animal medicines industry, our current members also already have a diverse product spread, including feed additives and nutraceuticals and an increasing interest in diagnostics and digital technologies,” she said. “This is something we can celebrate and work towards an even broader representation.

"As the future changes fast, catalysed by the pandemic, NOAH will change with the times to serve out modern and changing sector."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.